Dariohealth releases study demonstrating the impact of personalized digital interventions to improve self-management of diabetes

Study results to be presented at the 14th international conference on advanced technologies and treatments for diabetes new york, june 4, 2021 /prnewswire/ -- dariohealth corp. (nasdaq: drio), a leader in the global digital therapeutics (dtx) market, announced today it will be presenting results of a new study at the 14th international conference on advanced technologies and treatments for diabetes (attd 2021; june 2-5, 2021). the study, titled "impact of digital intervention engine on diabetes self-management," examined the effect of dariohealth's highly personalized digital journeys on both clinical and engagement outcomes, applying user-specific digital intervention flows for behavioral change to increase user digital engagement.
DRIO Ratings Summary
DRIO Quant Ranking